MedPath
Found 1 clinical trials|View Analysis
Sort by:

Feasibility of a New Diagnostic Device to Assess Small Intestinal Dysbiosis in Routine Clinical Setting.

Not Applicable
Recruiting
Conditions
Small Intestinal Bacterial Overgrowth
Interventions
Device: Atmo Gas Capsule
Procedure: Jejunal Aspiration and culture
Diagnostic Test: Glucose Breath Test
Diagnostic Test: Fructoolifosaccharides (FOS) Breath Test
Drug: Placebo
Drug: Rifaximin
First Posted Date
2021-06-02
Last Posted Date
2024-01-30
Lead Sponsor
Atmo Biosciences Pty Ltd
Target Recruit Count
150
Registration Number
NCT04910815
Locations
🇮🇳

Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India

🇦🇺

Princess Alexandra Hospital, Woolloongabba, Queensland, Australia

© Copyright 2025. All Rights Reserved by MedPath